EUR-1048
Collaboration Partner:
GlaxoSmithKline (GSK)
Indication:
Undisclosed
Status:
Biostudy
Profile:
EUR-1048 is an orally disintegrating tablet formulation that we are developing for GSK. We are using our Microcaps® taste-masking and AdvaTab® orally disintegrating tablet technologies in developing this product. We retain exclusive, worldwide manufacturing rights, and, under certain circumstances, both we and GSK may have rights to commercialize the product outside the United States.